Study for Regulation Mechanism and Specific Targets of Inhibition of Complement for Hepatic Alveolar Echinococcosis Host Immune Response

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022950

Enrollment

Unknown

Registered

2019-05-04

Start date

2019-05-04

Completion date

Unknown

Last updated

2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Alveolar Echinococcosis

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged 18-85 years old male and female patients who needs to be underwent surgical treatment including livertransplantation due to the disease.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women, anyone not willing to join in.

Design outcomes

Primary

Measure	Time frame
C3 RNA expression;C5 RNA expression;CD3 expression;CD19 expression;C3b expression;	—

Countries

China

Contacts

Public ContactWentao Wang

West China Hospital of Sichuan University

wwt02@163.com+86 18980601895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026